Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...

Full description

Saved in:

Bibliographic Details
Published in:	Emerging infectious diseases Vol. 26; no. 3
Main Authors:	Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick
Format:	Journal Article
Language:	English
Published:	United States Centers for Disease Control and Prevention 01.03.2020
Subjects:	Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Clinical outcomes Clinical practice guidelines Data collection data collection standards Data dictionaries evidence-based medicine Humans Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis International policy Laboratories Meta-analysis multidrug resistance Mycobacterium tuberculosis - drug effects Observational studies Observational Studies as Topic - standards Online Report Patients Quality Improvement Rifampin - pharmacology Rifampin - therapeutic use therapy data collection Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Pulmonary - drug therapy Womens health multidrug resistance data collection standards bacteria therapy data collection tuberculosis meta-analysis statistics and numerical data TB RR-TB antimicrobial resistance MDR TB practice guideline evidence-based medicine
ISSN:	1080-6040, 1080-6059, 1080-6059
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!